A RAndomizeD Intervention for CArdiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

30 August 2026 (11:00 - 11:15)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Darryl Leong

Population Health Research Institute, Hamilton (Canada)

3 More presentations in this session

Presentation thumbnail

An open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2 targeted therapy related cardiac dysfunction.

Doctor B. Dowsing (London, GB)

Presentation thumbnail

Incidence and Predictors of Arterial Thrombosis in Cancer Patients: The Prospective COMPASS-Arterial Cancer Associated Thrombosis (COMPASS-ARTeCAT) Study

Doctor M. Drakopoulou (Athens, GR)

Presentation thumbnail

Heart Failure and Incident Hematologic Malignancies: A Nationwide Population-Based Cohort Study

Doctor S. Lee (Seoul, KR)

Access the full session

Session thumbnail

Late-Breaking Clinical Science: cardio-oncology

The Event

Event poster

ESC Congress 2026

30 August 2026 11:00 CET

You may be interested in

Webinar

Understanding the cardiovascular risks in prostate cancer treatment

18 November 2025

Congress Presentation

Effect of individualized intelligent behavioral interventions on health behaviors for patients with coronary heart disease: an open-label, multicenter, parallel-group, randomized controlled trial

1 September 2025

Congress Presentation

Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors

5 April 2025

Congress Presentation

Effect of exercise training on cardiorespiratory fitness, quality of life and objectively measured physical activity in patients undergoing anthracycline-based chemotherapy: the Caprice RCT

28 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources